Company Overview and News
KUALA LUMPUR: Berjaya Land Bhd said it had to make a huge impairment charge in the third quarter because of a dispute over the balance of sales proceeds the company was supposed to receive from the disposal of a project in China two years ago.
MarketWatch: Wall Street dipped on Monday, as a selloff in technology shares weighed heavily on the Nasdaq, while the most recent statement from North Korea’s to Washington added to a cautious tone. The DJIA fell 53.84 points, or 0.24%, to 22,295.75, the S&P 500 lost 5.56 points, or 0.22%, to 2,496.66 and the Nasdaq dropped 56.33 points, or 0.88%, to 6,370.59. - Reuters
KUALA LUMPUR (March 23): Based on corporate announcements on Bursa Malaysia and news flow today, companies that may be in focus on Friday (March 24) could include the following: Aeon Credit Service (M) Bhd, Axiata Group Bhd, Telekom Malaysia Bhd, Utusan Melayu Malaysia Bhd, PLB Engineering Bhd, Scomi Group Bhd, Systech Bhd, Mitrajaya Holdings Bhd, Mexter Technology Bhd, Gamuda Bhd, Berjaya Land Bhd, Hiap Teck Venture Bhd, ML Global Bhd, Iris Corp Bhd, Integrated Logistics Bhd and Jaycorp Bhd.
KUALA LUMPUR (March 23): The FBM KLCI may stage a mild technical rebound this morning in line with the overnight recovery at Wall Street, and retrace back to above the 1,750-point level.
KUALA LUMPUR (March 22): Based on corporate announcements and news flow today, companies that may be in focus on Thursday (March 23) may include the following: Felda Global Ventures Holdings Bhd, Metronic Global Bhd, Halex Holdings Bhd, Uzma Bhd, Berjaya Land Bhd, Poh Huat Resources Holdings Bhd, Leon Fuat Bhd, AirAsia Bhd, Luster Industries Bhd and DRB-Hicom Bhd.
PETALING JAYA: Berjaya Land Bhd (BLand) will be exiting its Vietnam-based Berjaya Long Beach LLC (BLong Beach) business, as it will be selling its entire stake in the latter to Sulyna Hospitality Hotel Restaurant Travel Service Co Ltd for 333.25 billion dong or RM65.32mil.
KUALA LUMPUR (Feb 15): Based on corporate announcements and news flow today, companies that will be in focus tomorrow (Thursday, Feb 16) may include: Heineken Malaysia Bhd, Boustead Plantations Bhd, Berjaya Land Bhd (BLand), Gas Malaysia Bhd, RCE Capital Bhd, Wah Seong Corp Bhd, Wong Engineering Corp Bhd and Dagang NeXchange Bhd (DNeX).
Following a subdued week, the Dollar Index gained this week by +0.2%, closing at 100.38 on Thursday supported by the sell off in the US money market. Dow Jones Industrial Average hit the 20,000 milestone on Thursday, closing at 20,100.91 on the back of robust expectations for corporate earnings and pro-growth policies. S&P 500 gained +1.1% led by funds following into materials, banks, financials, consumer discretionary and info tech.
MarketWrap: US equities touched record highs on Tuesday and the dollar rose to its highest level in 14 years as markets shrugged off risk aversion and continued the rally that has elevated Wall Street since Election Day. - Reuters The DJIA rose 91.56 points, or 0.46%, to 19,974.62, the S&P 500 gained 8.23 points, or 0.3%, to 2,270.76 and the Nasdaq added 26.50 points, or 0.49%, to 5,483.94. Forex summary *The ringgit was up 0.
KUALA LUMPUR (Dec 21): The FBM KLCI is expected to remain trading sideways today, despite the overnight rally at Wall Street, as a lack of fresh catalysts will likely keep a lid on the local market.
KUALA LUMPUR (Dec 20): Based on corporate announcements and news flow today, companies that may be in focus on Thursday (Dec 21) could include: Priceworth International Bhd, AirAsia Bhd, George Kent (Malaysia) Bhd, UMW Holdings Bhd, Berjaya Land Bhd, Greenyield Bhd and Yinson Holdings Bhd.
MarketWrap: US stocks edged higher on Tuesday as an upbeat outlook from UnitedHealth lifted health insurers, though a sharp drop in oil prices weighed on energy shares and limited the advance. - Reuters The DJIA rose 23.7 points, or 0.12%, to 19,121.6, the S&P 500 gained 2.94 points, or 0.13%, to 2,204.66 and the Nasdaq added 11.11 points, or 0.21%, to end at 5,379.92. Forex summary *The ringgit gained 0.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...